Fan J, Bellon M, Ju M, Zhao L, Wei M, Fu L, et al. Clinical significance of FBXW7 loss of function in human cancers. Mol Cancer. 2022;21:87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Y, Zhou X, Liu X, Song R, Gao Y, Wang S. Implications of FBXW7 in neurodevelopment and neurodegeneration: Molecular mechanisms and therapeutic potential. Front Cell Neurosci. 2021;15:736008.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roversi G, Picinelli C, Bestetti I, Crippa M, Perotti D, Ciceri S, et al. Constitutional de novo deletion of the FBXW7 gene in a patient with focal segmental glomerulosclerosis and multiple primitive tumors. Sci Rep. 2015;5:15454.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ge Z, Leighton JS, Wang Y, Peng X, Chen Z, Chen H, et al. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types. Cell Rep. 2018;23:213–26.e3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mahamdallie S, Yost S, Poyastro-Pearson E, Holt E, Zachariou A, Seal S, et al. Identification of new Wilms tumour predisposition genes: an exome sequencing study. Lancet Child Adolesc Health. 2019;3:322–31.

Article  PubMed  PubMed Central  Google Scholar 

Stoltze UK, Hildonen M, Hansen TVO, Foss-Skiftesvik J, Byrjalsen A, Lundsgaard M, et al. Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort. J Med Genet. 2023;60:842–9.

Article  CAS  PubMed  Google Scholar 

Stephenson SEM, Costain G, Blok LER, Silk MA, Nguyen TB, Dong X, et al. Germline variants in tumor suppressor FBXW7 lead to impaired ubiquitination and a neurodevelopmental syndrome. Am J Hum Genet. 2022;109:601–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vujanić GM, Parsons LN, D’Hooghe E, Treece AL, Collini P, Perlman EJ. Pathology of Wilms’ tumour in International Society of Paediatric Oncology (SIOP) and Children’s oncology group (COG) renal tumour studies: Similarities and differences. Histopathology. 2022;80:1026–37.

Article  PubMed  Google Scholar 

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.

Article  PubMed  PubMed Central  Google Scholar 

Kohno T, Kato M, Kohsaka S, Sudo T, Tamai I, Shiraishi Y, et al. C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan. Cancer Discov. 2022;12:2509–15.

Article  PubMed  PubMed Central  Google Scholar 

Mertens F, Johansson B, Mitelman F. Isochromosomes in neoplasia. Genes, Chromosomes Cancer. 1994;10:221–30.

Article  CAS  PubMed  Google Scholar 

Meier-Abt F, Kraemer D, Braun N, Reinehr M, Stutz-Grunder E, Steindl K, et al. Further evidence that the neurodevelopmental gene FBXW7 predisposes to Wilms tumor. Am J Med Genet A. 2024;194:e63528. https://doi.org/10.1002/ajmg.a.63528

Article  CAS  PubMed  Google Scholar 

Zhou W, Wang C, Fu L, Shi W, Zhang A, Jia Z, et al. Copy number variants at 4q31.3 affecting the regulatory region of FBXW7 associated with neurodevelopmental delay. Clin Genet. 2024. https://doi.org/10.1111/cge.14548.

Kalish JM, Doros L, Helman LJ, Hennekam RC, Kuiper RP, Maas SM, et al. Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma. Clin Cancer Res. 2017;23:e115–e122.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scott RH, Walker L, Olsen ØE, Levitt G, Kenney I, Maher E, et al. Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice. Arch Dis Child. 2006;91:995–9.

Article  CAS  PubMed  PubMed Central  Google Scholar